Henry Meds vs LifeMD: Pricing and Program Structure Compared

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

A PlexusDx Education Hub comparison covering GLP-1 therapies, weight management protocols, and the genetics behind every metabolic decision. Browse all Peptides & GLP-1 education.

This is an independent editorial comparison. PlexusDx has no commercial relationship with Henry Meds or its parent company, and no affiliate links or compensation are involved. Henry Meds and LifeMD are two of many GLP-1 telehealth options as of April 2026; this piece focuses on the two brands named in the query.

Full head-to-head: PlexusDx vs Henry Meds →

Two different telehealth business models

Henry Meds operates as telehealth paired with a compounded pharmacy: virtual evaluation, provider-issued prescriptions, and either brand-name FDA-approved GLP-1 dispensing or compounded semaglutide and tirzepatide through licensed compounding-pharmacy pathways. LifeMD, by contrast, runs a subscription-telehealth model. Program structures, medication options, and pricing shift over time, so Henry Meds's official website and LifeMD's official website hold the current details.

How Henry Meds structures its medication pricing

Henry Meds prices per medication and advertises a low headline figure that requires paying twelve months up front, with a higher month-to-month rate. Here is Henry's published ladder, each figure labeled and verified July 20, 2026. Its flagship, injectable compounded semaglutide, is $297/month month-to-month; prepaid plans lower it, with the 6-month plan at $1,482 ($247/month) and the 12-month plan at $2,364 ($197/month). That advertised "$197/month" is the 12-month prepaid-in-full rate, not a month-to-month price.

The rest of Henry's ladder

Oral (sublingual) semaglutide runs $249/month month-to-month, with a $179/month tier. Oral tirzepatide is offered as dissolving tablets only - Henry does not offer an injectable tirzepatide as of July 2026 - sold as a 3-month supply at $1,047 ($891 paid in full), with no published month-to-month tirzepatide rate. Injectable liraglutide is $179/month month-to-month, and oral phentermine is $149/month. Henry charges no membership fee and no per-visit consultation fee: the provider evaluation is free, nothing is charged until a prescription is written, and the subscription bundles medication, supplies, shipping, and ongoing care. Its refund policy is not stated.

How LifeMD's subscription compares

LifeMD publishes its own pricing on its site. Rather than cite a possibly-stale number, verify LifeMD's current rates directly before any purchase decision, and confirm Henry's figures on Henry Meds's official website. The broad contrast is a per-medication compounded model at Henry versus a subscription structure at LifeMD.

Because Henry's rates are quoted per medication and per term while LifeMD packages care as a recurring subscription, the two resist a single-number comparison. The fairer approach is to line up the ongoing monthly cost for the specific medication you would actually use at each brand, then account for what each plan bundles, before treating either headline figure as your real spend.

Same compounds, different packaging

Both brands operate in the GLP-1 receptor agonist space. GLP-1 receptor agonists (semaglutide, liraglutide, dulaglutide) and GIP/GLP-1 dual agonists (tirzepatide) modulate appetite regulation, satiety signaling, and gastric emptying. The pharmacology is identical across any legitimate GLP-1 program; what differs is the business model, the dispensing pathway, provider oversight, and pricing. The trial record - STEP (NEJM 2021), SURMOUNT (NEJM 2022), and SURMOUNT-OSA (NEJM 2024) - reflects the compounds, with effect sizes varying by compound, dose, and population.

The variable neither platform maps: your genes

Neither Henry Meds nor LifeMD reads the genetics that shape a GLP-1 response. Variants in FTO (the fat-mass and obesity-associated gene), GLP1R (the GLP-1 receptor gene targeted by every GLP-1 compound), MC4R, and TCF7L2 describe the metabolic terrain a clinician prescribes into. These pathway-level signals do not predict response to any specific compound, but they add context a prescription alone misses. PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols - Semaglutide Injection at $189 per month, Tirzepatide Injection at $289 per month, plus Semaglutide Oral and Tirzepatide Oral. Before starting, the Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights, the test-before-you-invest step toward an informed conversation with your provider.

Not affiliated: PlexusDx is not affiliated with Henry Meds and has no commercial relationship with the companies reviewed here.

Related reading on PlexusDx: What Is GLP-1, GLP-1 What Is, GLP-1 Receptor Agonist, GLP-1 Drugs.

Frequently Asked Questions

Is Henry Meds cheaper than LifeMD?

It depends on the plan. Henry's low advertised rate reflects a 12-month prepaid-in-full commitment rather than a month-to-month price, and LifeMD publishes separate subscription pricing on its own site. Compare the ongoing rate you would actually pay at each brand, not just the headline figure, before deciding.

What does Henry's advertised low monthly price actually require?

For flagship injectable compounded semaglutide, the "$197/month" figure is the 12-month prepaid-in-full rate ($2,364 total). The month-to-month rate is $297, and a 6-month plan is $1,482 ($247/month). Read which term a quoted price assumes before treating it as your real monthly cost.

Does Henry Meds offer injectable tirzepatide?

As of July 2026, Henry offers oral tirzepatide as dissolving tablets only and does not list an injectable tirzepatide. It is sold as a 3-month supply at $1,047 ($891 paid in full), with no published month-to-month rate. Confirm current availability on Henry's own site.

How does the Precision Peptide Genetic Test fit this comparison?

It does not predict response to any compound or telehealth program. It reports pathway-level variants in FTO and MC4R, and TCF7L2 that describe baseline GLP-1 biology, context that applies across every GLP-1 program, whether you enroll with Henry Meds, LifeMD, or another brand.

This article is part of the PlexusDx Education Hub. Browse all Peptides & GLP-1 education.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.